Showing 541 - 560 results of 1,770 for search '(( i wt decrease ) OR ( 10 ((greater decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.20s Refine Results
  1. 541

    Aluminum nitride (AlN) reinforced electrodeposited Ni-B nanocomposite coatings by Radwan, A. Bahgat

    Published 2020
    “…The potentiodynamic analysis exhibited that the protection efficiency (PE%) of Ni–B coating is ~20%, which increased to ~53% and ~73% by addition of AlN nanoparticles of 0.6 and 1.2 g L−1, respectively. The corrosion resistance could be credited to the presence of inactive and insulating AlN nanoparticles that filled the existing defects in Ni–B matrix and subsequently decreased the active area exposed to the corrosive electrolyte (3.5 wt.% NaCl).…”
    Get full text
    Get full text
  2. 542

    Enhancing the corrosion resistance of reinforcing steel under aggressive operational conditions using behentrimonium chloride by Radwan A.B.

    Published 2019
    “…Using only a 50 ?mol L?1 of BTC, we are able to measure an inhibition efficiency of 91, 79, and 71% in SCP solution with 3.5% NaCl at pH of 12.5, 10 and 7, respectively without showing any effect on the mechanical properties on the cured mortars. …”
    Get full text
    Get full text
  3. 543
  4. 544
  5. 545

    Flow and Fracture Behaviour of Tungsten Fiber Reinforced Superalloy Composites-Effect Of Specimen Geometry by Kandeil, A. Y.

    Published 1989
    “…I. niaxial compression forging was performed at a constant true strain rate of 3x10^ S , with temperature as parameter. …”
    Get full text
  6. 546
  7. 547
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557
  18. 558

    Novel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model by Al-Awar A.

    Published 2018
    “…Sitg oral treatment of different doses (25, 50, 100, and 150 mg/kg/day), or saline as a Control. Hearts were then isolated and subjected to two different I/R injury protocols: 10 min perfusion, 45 min regional ischemia, and 120 min reperfusion for infarct size (IS) measurement, or: 10 min perfusion, 45 min regional ischemia and 10 min reperfusion for biochemical analysis: nitric oxide synthases (NOSs) and DPP-4 activity, glucagon-like peptide-1 (GLP-1), Calcium, transient receptor potential vanilloid (TRPV)-1 and calcitonin gene-related peptide (CGRP) levels, transient receptor potential canonical (TRPC)-1 and e-NOS protein expression. …”
    Get full text
    Get full text
  19. 559
  20. 560